Medical Device Network on MSN
Butterfly Medical raises $21M in funds for BPH device development
The company has completed its pivotal clinical trial for the Butterfly prostatic retraction device.
Data Supported the FDA Approval of the Zenflow Spring® Implant and Delivery System for BPH Additional presented data highlights patient satisfaction & long-term safety SOUTH SAN FRANCISCO, Calif., May ...
Teleflex announces favorable results for UroLift™ in treating BPH, showing higher patient satisfaction and better early recovery compared to Rezūm. Teleflex Incorporated announced new results from the ...
An enlarged prostate is benign and usually results from changes in cell growth. A doctor can advise on the best medication for an individual. Options include alpha-blockers, inhibitors, and ...
"There's nothing else like Optilume BPH that's currently available, it's the only treatment option that requires no cutting, burning, steaming or implants," said Urotronic President and CEO David ...
In the realm of health supplements, few products target men’s health concerns with as much focus and effectiveness as PhytAge Labs Prostate 911. As men age, prostate health becomes a critical issue; ...
SOUTH SAN FRANCISCO, Calif., May 18, 2026 (GLOBE NEWSWIRE) -- Zenflow, Inc. recently presented data from its BREEZE™ pivotal clinical trial demonstrating the efficacy and safety of the Zenflow Spring® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results